1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with 1-methyl-4-phenylpyridinium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bähr, M; Frank, T; Koch, JC; Lingor, P; Saal, KA; Szego, ÉM; Tatenhorst, L; Tönges, L; Weishaupt, JH | 1 |
1 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 1-Methyl-4-phenylpyridinium; Animals; Axons; Behavior, Animal; Cell Survival; Cells, Cultured; Corpus Striatum; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nerve Degeneration; Neurites; Neuroprotective Agents; Parkinson Disease, Secondary; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; rho-Associated Kinases; Substantia Nigra | 2012 |